Tibor Keler, PhD
Celldex Therapeutics, IncTibor Keler is co-founder and Chief Scientific Officer of Celldex Therapeutics. His research has focused on the discovery and application of antibodies and recombinant proteins for immunotherapy, with recent efforts directed toward developing antibody and bispecific antibody approaches targeting KIT and SCF to inhibit or deplete mast cells for the potential treatment of allergic, inflammatory, and fibrotic diseases.
Website
Affiliation
Chief Scientific Officer and Co-Founder
Celldex Therapeutics, Inc
Hampton, New Jersey
USA